Literature DB >> 8245449

CD28-mediated costimulation is necessary for the activation of T cell receptor-gamma delta+ T lymphocytes.

A I Sperling1, P S Linsley, T A Barrett, J A Bluestone.   

Abstract

The role of costimulation in the activation of TCR-gamma delta cells in normal mice and mice transgenic (tg) for a TCR-gamma delta receptor was investigated. Activation of TCR-gamma delta cells required two signals. One signal was mediated by TCR occupancy, whereas a second signal was provided by accessory cells. The importance of the CD28/B7 interaction in the delivery of the second signal was demonstrated in multiple ways. First, addition of a soluble fusion protein homolog of CD28, CTLA4Ig, significantly inhibited the activation of G8 tg splenic TCR-gamma delta lymphocytes and intestinal epithelial TCR-gamma delta lymphocytes by Ag-bearing lymphocytes during primary stimulation. Similarly, both proliferation and IFN-gamma production were inhibited by addition of CTLA4Ig to secondary antigenic stimulation of G8 tg TCR-gamma delta cells. Second, an Ag-bearing thymoma, EL-4, was only able to stimulate expanded G8 tg TCR-gamma delta cells when the thymoma expressed B7. This stimulation was blocked by both CTLA4Ig and anti-B7 antibody. Third, antibodies to CD28 were able to mimic the costimulatory affect of APC. TCR-gamma delta cells cultured with either Ag-bearing fixed stimulator cells or submitogenic concentrations of immobilized anti-pan TCR-gamma delta mAb proliferated only in the presence of anti-CD28 mAb. Finally, G8 tg cells produced IL-2 only in the presence of APC costimulation or anti-CD28 antibodies, and the addition of exogenous rIL-2 overcame the need for costimulation. Thus, autocrine IL-2 production is one of the major consequences of TCR-gamma delta cell costimulation. Together these data demonstrate that costimulation is necessary for the activation of TCR-gamma delta cells and can occur through CD28 interaction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245449

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Searching for "signal 2": costimulation requirements of γδ T cells.

Authors:  Julie C Ribot; Ana debarros; Bruno Silva-Santos
Journal:  Cell Mol Life Sci       Date:  2011-05-04       Impact factor: 9.261

2.  A subset of gamma delta T-cell receptor-positive cells produce T-helper type-2 cytokines and regulate mouse skin graft rejection following portal venous pretransplant preimmunization.

Authors:  R M Gorczynski; Z Chen; Y Hoang; B Rossi-Bergman
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

Review 3.  TCR gamma delta cells: mysterious cells of the immune system.

Authors:  R Sciammas; Y Tatsumi; A I Sperling; K Arunan; J A Bluestone
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

Review 4.  γδ T cell receptor ligands and modes of antigen recognition.

Authors:  Eric Champagne
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2011-02-06       Impact factor: 4.291

5.  Mycobacterium tuberculosis induces apoptosis in gamma/delta T lymphocytes from patients with advanced clinical forms of active tuberculosis.

Authors:  R Duarte; J M Kindlelán; J Carracedo; P Sánchez-Guijo; R Ramírez
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

Review 6.  Engineering γδ T Cells: Recognizing and Activating on Their Own Way.

Authors:  Ruoyu Dong; Yixi Zhang; Haowen Xiao; Xun Zeng
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

7.  Characterizing a soluble survival signal for activated lymphocytes from CD14+ cells.

Authors:  Xiaolei Tang; David E Yocum; David DeJonghe; Kathy Nordensson
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

8.  Keratinocyte expression of B7-1 in transgenic mice amplifies the primary immune response to cutaneous antigens.

Authors:  I R Williams; R J Ort; T S Kupper
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

Review 9.  The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma.

Authors:  Susann Schönefeldt; Tamara Wais; Marco Herling; Satu Mustjoki; Vasileios Bekiaris; Richard Moriggl; Heidi A Neubauer
Journal:  Cancers (Basel)       Date:  2021-12-09       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.